Assignee
FTF PHARMA PRIVATE LTD
IN·5 granted patents·17 pending applications·17 citations·filing 2015–2023
Top patents by PatentIndex Score
22 records- 0195US12016857B2Stable liquid vigabatrin pharmaceutical composition for oral dosageFTF PHARMA PRIVATE LTD·Filed 2023·Granted Jun 25, 2024·3 cites·12 claims
- 0290US11738020B2Stable liquid vigabatrin pharmaceutical composition for oral dosageFTF PHARMA PRIVATE LTD·Filed 2019·Granted Aug 29, 2023·3 cites·11 claims
- 0384US11147810B2Pharmaceutical composition of oral suspension of anti-neoplastic alkylating agentsFTF PHARMA PRIVATE LTD·Filed 2018·Granted Oct 19, 2021·6 cites·4 claims
- 0483US10314880B2Composition comprising bortezomibFTF PHARMA PRIVATE LTD·Filed 2016·Granted Jun 11, 2019·5 cites·7 claims
- 0575US2024122846A1Pharmaceutical composition comprising an androgen receptor inhibitorFTF PHARMA PRIVATE LTD·Filed 2023·Application pending·0 cites
- 0675US2021308044A1Pharmaceutical suspension for oral dosageFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 0765US11147817B2Pharmaceutical composition of pemetrexedFTF PHARMA PRIVATE LTD·Filed 2020·Granted Oct 19, 2021·0 cites·18 claims
- 0857US2019209469A1Pharmaceutical composition comprising an androgen receptor inhibitorFTF PHARMA PRIVATE LTD·Filed 2017·Application pending·0 cites
- 0957US2022347122A1Solutions for oral dosageFTF PHARMA PRIVATE LTD·Filed 2020·Application pending·0 cites
- 1053US2020188478A1Pre-mixed, ready to use vancomycin compositionsFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 1152US2022105000A1Stable parenteral dosage form of pyrazolone derivativeFTF PHARMA PRIVATE LTD·Filed 2021·Application pending·0 cites
- 1252US2019290718A1Composition comprising bortezomibFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 1351US2022280463A1Pharmaceutical formulations comprising diclofenacFTF PHARMA PRIVATE LTD·Filed 2020·Application pending·0 cites
- 1451US2021059967A1Liquid parenteral compositions of levothyroxineFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 1550US2021030671A1Liquid dosage forms of cinacalcet or salt thereofFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 1650US2021213024A1Liquid compositions of aprepitantFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 1749US2017340639A1Pharmaceutical composition of pemetrexedFTF PHARMA PRIVATE LTD·Filed 2015·Application pending·0 cites
- 1847US2020022910A1Pharmaceutical composition of oral solution of muscarinic antagonistFTF PHARMA PRIVATE LTD·Filed 2018·Application pending·0 cites
- 1945US2020046664A1Method for preparation of liquid oral composition of l-thyroxinFTF PHARMA PRIVATE LTD·Filed 2017·Application pending·0 cites
- 2036US2018303811A1Oral solution of dihydropyridine derivativesFTF PHARMA PRIVATE LTD·Filed 2016·Application pending·0 cites
- 2134US2018147148A1Pharmaceutical composition of teriflunomideFTF PHARMA PRIVATE LTD·Filed 2016·Application pending·0 cites
- 2231US2015328165A1Pharmaceutically acceptable dosage form comprising release of multiple drugs from single oral dosage formFTF PHARMA PRIVATE LTD·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →